Skip to content
★ Sign in to follow
MT

Matteo Trotta

Executive
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 26 Mar 2026 for Incyte Corp, €43k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Matteo Trotta: trading record in brief

Matteo Trotta discloses dealings in Incyte Corp to SEC (Form 4). Between 25 March 2024 and 25 March 2026, the trades on record add up to 6 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 26 March 2026, the filings show a share grant worth €43k in Incyte Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Matteo Trotta

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    EVP, GM, Dermatology USExecutivesIncyte Corp
    49,528 USD16SEC
    537 shares@ US$92.2350.6% of flowCommon StockSEC:0002015975-26-000006:0
  • ◆
    EVP, GM, Dermatology USExecutivesIncyte Corp
    12,422 USD12SEC
    182 shares@ US$68.2512.7% of flowCommon StockSEC:0000879169-25-000089:0
  • ◆
    EVP, GM, Dermatology USExecutivesIncyte Corp
    33,337 USD15SEC
    537 shares@ US$62.0836.6% of flowCommon StockSEC:0001628280-25-015196:0
  • ◆
    EVP, GM, Dermatology USExecutivesIncyte Corp
    0SEC
    2,646 shares0Common StockSEC:0000879169-24-000135:0
  • ◆
    EVP, GM, Dermatology USExecutivesIncyte Corp
    0SEC
    7,828 shares0Common StockSEC:0000879169-24-000066:0

5 of 5 declarations